Initial Public Offering (IPO): Registration Statement (General Form) — Form S-1
Filing Table of Contents
Document/Exhibit Description Pages Size
1: S-1 Form S-1 Prestwick Pharmaceuticals, Inc. HTML 1.18M
2: EX-3.1 Form of Amended and Restated Certificate of HTML 24K
Incorporation
3: EX-3.2 Amended and Restated Bylaws HTML 128K
4: EX-4.2 Amended and Restated Investor Rights Agreement HTML 190K
9: EX-10.10 Amended and Restated Agreement -- Cambridge HTML 187K
Laboratories
10: EX-10.11 Agreement Dated February 2, 2004 HTML 51K
11: EX-10.12 Development and Commercialization License and HTML 268K
Clinical Supply Agreement
12: EX-10.13 License Agreement -- Dr. Maurice W. Gittos HTML 78K
13: EX-10.14 License Agreement -- the General Hospital HTML 75K
Corporation
14: EX-10.15 Letter Agreement -- Melvin D. Booth HTML 29K
15: EX-10.16 Letter Agreement -- David A. Cory HTML 25K
16: EX-10.17 Letter Agreement -- Christopher F. O'Brien HTML 25K
17: EX-10.18 Letter Agreement -- James P. Shaffer HTML 23K
18: EX-10.19 Letter Agreement -- William H Washecka HTML 22K
19: EX-10.20 Letter Agreement -- Benjamin P. Lewis HTML 18K
20: EX-10.21 Separation Agreement -- Robert S. Whitehead HTML 65K
21: EX-10.22 Letter Agreement -- Mark Van Ausdal HTML 66K
5: EX-10.5 Form of Indemnification Agreement HTML 72K
6: EX-10.6 Asset Purchase and Subscription Agreement HTML 188K
7: EX-10.7 Executive Employment Agreement - Kathleen HTML 54K
Clarence-Smith, M.D., Ph.D.
8: EX-10.9 Agreement for Canadian Rights to Nitoman HTML 204K
22: EX-21.1 Subsidiaries of the Registrant HTML 8K
23: EX-23.2 Consent of Experts or Counsel HTML 9K
EX-21.1 — Subsidiaries of the Registrant
This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]
